Cite
HARVARD Citation
Murray, M. et al. (2018). Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial. HIV clinical trials. 19 (4), pp. 129-138. [Online].